Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Presentations

LPCN 1148 Presentation

Download the Presentation

Markman Hearing Order

Download the Presentation

Corporate Presentation

Download the Presentation

LPCN 1144 Presentation

Download the Presentation